Vascular Verification Program

National Quality Verification Program for Vascular Care logo

 

 

 

Why is the Vascular Verification Program Important for Your Institution? 

With the confounding issues facing healthcare c-suites today, it can be difficult to impress how the Vascular Verification Program works strategically to improve outcomes for the patient and hospital by prioritizing efforts to increase effective and efficient delivery of care—reducing risk for post-operative negative consequences. 

Please download this PowerPoint to help facilitate the conversation or contact SVSQuality@vascularsociety.org to schedule a consultation with one of our SVS Vascular Verification leaders to discuss working with your c-suite.

Download Here

Remote video URL

 

Surgeons over operating table

The American College of Surgeons (ACS), in collaboration with the Society for Vascular Surgery (SVS), proudly presents the Vascular Verification Program—a national quality verification program designed to support the ongoing advancement and long-term sustainability of care for patients receiving vascular surgical and interventional services in the inpatient setting.

Since its inception, over a dozen centers nationwide have achieved verification, reflecting both the program’s rigorous standards and growing national momentum among leading institutions committed to sustained excellence in vascular care.

A Framework for Long-Term Excellence

Recognizing the complexity and breadth of vascular care, the program provides an enduring, evidence-driven framework that supports both the development and continuous maturation of quality improvement and clinical care infrastructure over time.

Designed for Programs at Every Stage

With two levels of participation, the Vascular Verification Program engages centers across the spectrum of care—offering a structured pathway to:

  • Benchmark progress 
  • Demonstrate sustained commitment to excellence 
  • Continuously advance quality and performance 

By supporting continuous improvement, the program helps ensure a lasting impact on patient outcomes and program performance.

ACS/SVS VVP Accredited Hospitals (as of July 2026)

Albany Medical Center – Inpatient and Outpatient

Ascension St. Vincent Indianapolis Hospital 

Baylor Scott & White The Heart Hospital – Dallas 

Baylor Scott & White The Heart Hospital – Plano 

Corewell Health Butterworth Hospital 

Froedtert and the Medical College of Wisconsin Froedtert Hospital 

Keck Hospital of USC 

Memorial Regional Hospital 

Michigan Vascular Center 

Rochester General Hospital 

St. Mary Hospital and Medical Center 

UCSF Medical Center

University of Tennessee Medical Center 

Vascular Institute of New York 

WellSpan York Hospital

Become a Vascular-VP Center

As a program uniquely focused on the care of vascular surgical and interventional patients in an inpatient setting, the Vascular Verification Program offers an opportunity to chart the progress of your center's program while also setting benchmarks and goals to continue the quality improvement journey of vascular science. 

Apply Now

Videos to Learn More

Remote video URL

If you have questions about the Vascular Verification Program, please contact us at vascular@facs.org

2016 VQI Participation Awards

Article

The SVS Patient Safety Organization has announced the winners of the 2016 VQI Participation Awards. This program, in its second year, recognizes the importance of active participation in the VQI as a critical component of the quality improvement mission.

Enrollment begins for PRESERVE, large study of IVC filters

Press Release

As of mid-December, researchers have activated the first 10 medical sites and enrolled the first nine patients in a study that will determine the safety and effectiveness of inferior vena cava filters, small, cage-like devices implanted to prevent life-threatening blood clots from reaching the heart or lungs. While vein filters have been in use for years, PRESERVE (Predicting the Safety and Effectiveness of Inferior Vena Cava Filters), is the first large-scale, multispecialty, prospective clinical research trial that will evaluate their real world safety and effectiveness. The inferior vena cava is the main vessel returning blood from the lower half of the body to the heart.